Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
BCBS Wellmark Medical Policy Updates – December 2018
Click here to view the Blue Cross Blue Shield Wellmark Medical Policy Updates »
December 2018 BCBS Wellmark Medical Policy Updates:
- Analysis of MGMT Promoter Methylation
- Bioimpedance Devices for Detection and Management of Lymphedema
- Biomarker Testing for Autoimmune Disease
- CAR-T Cell Therapy and Adoptive Immunotherapy*
- Cellular Immunotherapy for Prostate Cancer – Provenge (Sipuleucel-T)
- Corneal Cross-Linking
- Detection and Quantification of Circulating Tumor Cells in the Management of Patients with Cancer
- Diaphragmatic/Phrenic Nerve Stimulation and Diaphragm Pacing Systems
- DNA-Based Testing for Adolescent Idiopathic Scoliosis
- Dry Needling
- Enzyme Replacement Therapy for Lysosomal Storage Diseases
- Eustachian Tube Dysfunction Treatment
- Evzio (naloxone auto-injector)
- Exondys 51 (eteplirsen)
- Expanded Genetic Panels to Assess Cancer Risk
- Expanded Genetic Panels to Identify Targeted Cancer Therapy
- Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome (e.g. Lipiflow)
- Gene Expression Based Assays for Cancer of Unknown Primary
- Gene Expression Profiling for Cutaneous Melanoma
- Genetic Testing for BCR-ABL Fusion Gene
- Genetic Testing for FLT3, NPM1, and CEBPA Mutations
- Genetic Testing of BRCA for Indications Outside of Breast and Ovarian Cancers*
- Heart/Lung Transplant*
- Hematopoietic Stem Cell Transplantation (Bone Marrow Transplant) Autologous and Allogeneic*
- High Dollar Drug Review
- Home Sleep Studies – Pediatric
- Implantable Peripheral Nerve Stimulation for the Treatment of Chronic Pain
- Janus Kinase 2 (JAK2) V617F Gene Mutation Assay
- Kymriah (Tisagenlecleucel)*
- Leadless Cardiac Pacemaker
- Lung and Lobar Lung Transplant*
- Lutathera (Lutetium Lu 177 Dotatate)*
- Miscellaneous Electrical Stimulation
- Molecular Markers in Fine Needle Aspirates of the Thyroid
- Naltrexone
- Noninvasive Measurement of Cardiac Bioimpedance in the Outpatient Setting
- Off-label Drug Use
- Oncotype DX Breast
- Page not found | Wellmark
- Page not found | Wellmark
- Percutaneous Kyphoplasty, Percutaneous Vertebroplasty, and Sacroplasty
- Peripheral Subcutaneous Field Stimulation (PSFS)
- Pharmacogenomic Testing for Drug Metabolism
- Positron Emission Tomography (PET) for Surveillance of Oncologic Indications*
- Prostate-Specific Antigen Screening for Prostate Cancer
- Proteomic Testing for Lung Cancer
- Proton Beam Radiation Therapy*
- Radiofrequency Ablation of Peripheral Nerves to Treat Chronic Knee Pain and Plantar Fasciitis*
- Radium Ra 223 Dichloride (Xofigo)
- Small Bowel Transplant*
- Small Bowel/Liver and Multivisceral Transplant*
- Speech Generating Devices
- Stem Cell Therapy for Orthopedic Indications*
- Stem Cell Therapy for Peripheral Arterial Disease
- Stereotactic Surgery and Stereotactic Radiosurgery
- Surgical Treatment of Lymphedema
- Yescarta (Axicabtagene Ciloleucel)*
Click here to view the Blue Cross Blue Shield Wellmark Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
